Publications list | EBMT

Top

Area

Group

Year

Disease

Text

Haploidentical Versus Matched Sibling Donor Hematopoietic Stem Cell Transplantation for Adult Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia: A Study From the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

Acute Leukemia Working Party (ALWP)

1st listed author

Comparative study of treosulfan plus Fludarabine (FT14) with busulfan plus Fludarabine (FB4) for acute myeloid leukemia in first or second complete remission: An analysis from the European Society for Blood and Marrow Transplantation (EBMT) Acute Leukemia Working Party (ALWP)

Acute Leukemia Working Party (ALWP)

1st listed author

Eleni Gavriilaki

Bone Marrow Transplant.

Trends in outcome of transplantation in patients with secondary acute myeloid leukemia: an analysis from the Acute Leukemia Working Party (ALWP) of the EBMT

Acute Leukemia Working Party (ALWP)

1st listed author

Bone Marrow Transplant.

Should anti-thymocyte globulin be added in post-transplant cyclophosphamide based matched unrelated donor peripheral blood stem cell transplantation for acute myeloid leukemia? A study on behalf of the Acute Leukemia Working Party of the EBMT

Acute Leukemia Working Party (ALWP)

1st listed author

Alexandros Spyridonidis

Bone Marrow Transplant.

Measurable residual disease (MRD) status before allogeneic hematopoietic cell transplantation impact on secondary acute myeloid leukemia outcome. A Study from the Acute Leukemia Working Party (ALWP) of the European society for Blood and Marrow Transplantation (EBMT)

Acute Leukemia Working Party (ALWP)

1st listed author

Bone Marrow Transplant.

Outcome of human umbilical cord blood stem cell transplantation (CBT) for acute myeloid leukemia in patients achieving first complete remission after one versus two induction courses: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT)

Acute Leukemia Working Party (ALWP)

1st listed author

Bone Marrow Transplant.

Impact of the addition of antithymocyte globulin to post-transplant cyclophosphamide in haploidentical transplantation with peripheral blood compared to post-transplant cyclophosphamide alone in acute myeloid leukemia: a retrospective study on behalf of the Acute Leukemia Working Party of the EBMT

Acute Leukemia Working Party (ALWP)

1st listed author

Giorgia Battipaglia

Transplant Cell Ther.

Indications for haematopoietic cell transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2022

Acute Leukemia Working Party (ALWP)

Severe Aplastic Anaemia Working Party (SAAWP)

Autoimmune Diseases Working Party (ADWP)

Chronic Malignancies Working Party (CMWP)

Cellular Therapy & Immunobiology Working Party (CTIWP)

Inborn Errors Working Party (IEWP)

Infectious Diseases Working Party (IDWP)

Transplant Complications Working Party (TCWP)

Lymphoma Working Party (LWP)

Paediatric Diseases Working Party (PDWP)

1st listed author

Bone Marrow Transplant.

Defibrotide-treated patients with anicteric or icteric veno-occlusive disease/sinusoidal obstruction syndrome after hematopoietic cell transplantation: an EBMT study

Acute Leukemia Working Party (ALWP)

1st listed author

Bone Marrow Transplant.

Comparison of fludarabine-melphalan and fludarabine-treosulfan as conditioning prior to allogeneic hematopoietic cell transplantation-a registry study on behalf of the EBMT Acute Leukemia Working Party

Acute Leukemia Working Party (ALWP)

1st listed author

Jesus Duque-Afonso

Bone Marrow Transplant.

Post-transplant cyclophosphamide in one-antigen mismatched unrelated donor transplantation versus haploidentical transplantation in acute myeloid leukemia: a study from the Acute Leukemia Working Party of the EBMT

Acute Leukemia Working Party (ALWP)

1st listed author

Giorgia Battipaglia

Bone Marrow Transplant.

Total body irradiation plus fludarabine versus thiotepa, busulfan plus fludarabine as a myeloablative conditioning for adults with acute lymphoblastic leukemia treated with haploidentical hematopoietic cell transplantation. A study by the Acute Leukemia Working Party of the EBMT

Acute Leukemia Working Party (ALWP)

1st listed author

Ryszard Swoboda

Bone Marrow Transplant.